Novocure · 5 hours ago
Office Administrator
Novocure is dedicated to making a difference in cancer treatment. The Office Administrator will support the smooth operation of daily office functions, providing assistance to various teams including Human Resources and Accounting while managing office supplies and coordinating meetings.
BiotechnologyHealth CareMedical DeviceOncology
Responsibilities
Serve as the first point of contact for office visitors, phone calls, and general inquiries while maintaining security awareness
Maintain office supplies, equipment, and overall office organization
Schedule and coordinate meetings, luncheons, booking of conference room, catering and other events (Townhalls, holiday celebrations, etc)
Covers vacation and time off for the office administrator at 195 Commerce Way and the Sr. Office administrator at 180 Hanover Street
Handle incoming and outgoing correspondence, including mail, packages, and electronic communications
Provide calendar management and travel support for leadership team members as requested
Handles occasional trips to UPS, USPS, and FedEx
Work closely with the facilities team on any topics related to the building
Assist HR specialists with administrative tasks such as preparing documents, scheduling interviews, and supporting employee onboarding activities
Tidy and maintain the reception area
Order and maintain office and break room supplies
Other duties as requested
Qualification
Required
High school diploma or equivalent required; Associate's or Bachelor's degree preferred
2+ years of administrative or office support experience, preferably in a corporate environment
Strong organizational skills and attention to detail
Excellent written and verbal communication skills
Proficiency in Microsoft Office Suite (Word, Excel, Outlook, PowerPoint)
Ability to manage multiple priorities and deadlines
Discretion in handling confidential and sensitive information
Ability to lift up to 20 pounds
Preferred
Associate's or Bachelor's degree
Company
Novocure
An Oncology Company Pioneering a Novel Therapy for Solid Tumors
Funding
Current Stage
Public CompanyTotal Funding
$1BKey Investors
Pharmakon AdvisorsJP Morgan ChaseBioPharma Credit
2024-05-02Post Ipo Debt· $100M
2020-11-09Post Ipo Debt· $150M
2020-11-05Post Ipo Debt· $575M
Recent News
2026-01-13
Company data provided by crunchbase